Serial Number
79308218
Owner
Idorsia Pharmaceuticals LtdAttorney
Mary Margaret L. O'DonnellFiling Date
Dec 30, 2020
IDSIQ Trademark
Serial Number: 79308218 • Registration: 6726798
Trademark Classes
Class 9 - Computers & Electronics
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 16 - Paper Goods
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
December 30, 2020
Registration Date
May 24, 2022
Published for Opposition
March 1, 2022
Goods & Services
Downloadable electronic publications in the nature of newsletters and test results in the nature of test results documents and test result forms the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients
Multimedia publication of printed matter in the nature of newsletters, brochures, and test results in the nature of test results documents and test result forms in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients; multimedia publication of printed matter in the nature of books, magazines and journals in the field of tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients
Printed matter in the nature of newsletters and brochures in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients
Scientific research and development, namely pharmaceutical testing and medical testing services not for diagnostic or treatment purposes and development of pharmaceutical and medical tests, all which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients; scientific research, namely analysis of objective data on patients that was acquired by means of diagnostic tests in the context of drug administration, analysis of subjective data on patients that was acquired by means of patient questioning, analysis of such data with the aim of optimizing drug treatments and drug administration
